Module

Contending With HBV Resistance: Lessons Learned From HIV Resistance and Its Management

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Contending With HBV Resistance: Lessons Learned From HIV Resistance and Its Management


Faculty:

  • Douglas Richman, MD

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Compare and contrast HBV and HIV infections
  • Discuss strategies to combat HBV drug resistance
  • Discuss antiviral drugs and their potency in the HBV infection setting

Topics covered include:

  • Introduction
  • Comparison of HIV and HBV
  • Replication Capacity and Viral Fitness
  • Archived Virus and Reservoirs
  • Nucleos(t)ide Resistance: HIV and HBV
  • Strategies to Prevent the Development of Drug Resistance
  • Conclusion
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.